These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15541957)

  • 1. Transcription profiling of gene expression in drug discovery and development: the NCI experience.
    Sausville EA; Holbeck SL
    Eur J Cancer; 2004 Nov; 40(17):2544-9. PubMed ID: 15541957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of oncology drug response markers using transcription profiling.
    Dracopoli NC
    Curr Mol Med; 2005 Feb; 5(1):103-10. PubMed ID: 15720273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From correlation to causality: microarrays, cancer, and cancer treatment.
    O'Neill GM; Catchpoole DR; Golemis EA
    Biotechniques; 2003 Mar; Suppl():64-71. PubMed ID: 12664688
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics.
    Celis JE; Kruhøffer M; Gromova I; Frederiksen C; Ostergaard M; Thykjaer T; Gromov P; Yu J; Pálsdóttir H; Magnusson N; Orntoft TF
    FEBS Lett; 2000 Aug; 480(1):2-16. PubMed ID: 10967322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of toxicogenomics in drug development.
    Gant TW
    Drug News Perspect; 2003 May; 16(4):217-21. PubMed ID: 12942151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression microarray technologies in the development of new therapeutic agents.
    Clarke PA; te Poele R; Workman P
    Eur J Cancer; 2004 Nov; 40(17):2560-91. PubMed ID: 15541959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarrays to identify new therapeutic strategies for cancer.
    Sears C; Armstrong SA
    Adv Cancer Res; 2007; 96():51-74. PubMed ID: 17161676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer target discovery using SAGE.
    Porter D; Polyak K
    Expert Opin Ther Targets; 2003 Dec; 7(6):759-69. PubMed ID: 14640911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAGE and related approaches for cancer target identification.
    Porter D; Yao J; Polyak K
    Drug Discov Today; 2006 Feb; 11(3-4):110-8. PubMed ID: 16533708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacogenomics and transcriptional profiling in early phase oncology clinical trials.
    Burczynski ME; Oestreicher JL; Cahilly MJ; Mounts DP; Whitley MZ; Speicher LA; Trepicchio WL
    Curr Mol Med; 2005 Feb; 5(1):83-102. PubMed ID: 15720272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug target discovery by gene expression analysis: cell cycle genes.
    Walker MG
    Curr Cancer Drug Targets; 2001 May; 1(1):73-83. PubMed ID: 12188893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in transcription profiling of human cancer.
    Sültmann H; Poustka A
    Curr Opin Mol Ther; 2004 Dec; 6(6):593-9. PubMed ID: 15663323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets.
    Mayburd AL; Golovchikova I; Mulshine JL
    Bioinformatics; 2008 Feb; 24(3):389-95. PubMed ID: 17925305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gene expression database for the molecular pharmacology of cancer.
    Scherf U; Ross DT; Waltham M; Smith LH; Lee JK; Tanabe L; Kohn KW; Reinhold WC; Myers TG; Andrews DT; Scudiero DA; Eisen MB; Sausville EA; Pommier Y; Botstein D; Brown PO; Weinstein JN
    Nat Genet; 2000 Mar; 24(3):236-44. PubMed ID: 10700175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
    Bild AH; Yao G; Chang JT; Wang Q; Potti A; Chasse D; Joshi MB; Harpole D; Lancaster JM; Berchuck A; Olson JA; Marks JR; Dressman HK; West M; Nevins JR
    Nature; 2006 Jan; 439(7074):353-7. PubMed ID: 16273092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA array-based gene profiling: from surgical specimen to the molecular portrait of cancer.
    Mocellin S; Provenzano M; Rossi CR; Pilati P; Nitti D; Lise M
    Ann Surg; 2005 Jan; 241(1):16-26. PubMed ID: 15621987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data.
    Blower PE; Yang C; Fligner MA; Verducci JS; Yu L; Richman S; Weinstein JN
    Pharmacogenomics J; 2002; 2(4):259-71. PubMed ID: 12196914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of oligonucleotide-microarray and serial analysis of gene expression (SAGE) in transcript profiling analysis of megakaryocytes derived from CD34+ cells.
    Kim HL
    Exp Mol Med; 2003 Oct; 35(5):460-6. PubMed ID: 14646601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a porcine skeletal muscle cDNA microarray: analysis of differential transcript expression in phenotypically distinct muscles.
    Bai Q; McGillivray C; da Costa N; Dornan S; Evans G; Stear MJ; Chang KC
    BMC Genomics; 2003 Mar; 4(1):8. PubMed ID: 12611633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitivity prediction by transcriptional profiling.
    Staunton JE; Slonim DK; Coller HA; Tamayo P; Angelo MJ; Park J; Scherf U; Lee JK; Reinhold WO; Weinstein JN; Mesirov JP; Lander ES; Golub TR
    Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10787-92. PubMed ID: 11553813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.